Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-016764
Filing Date
2017-06-20
Accepted
2017-06-20 16:12:49
Documents
1
Period of Report
2017-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5876
  Complete submission text file 0000899243-17-016764.txt   7246
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

EIN.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORNERSTONE THERAPEUTICS INC. 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518
Business Address
Heffernan Michael Thomas (Reporting) CIK: 0001448914 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 17920977